On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...